DGRO vs XLV
iShares Core Dividend Growth ETF vs Health Care Select Sector SPDR Fund
- • DGRO pays a higher dividend yield (1.84%).
Side-by-side metrics
| Metric | DGRO | XLV |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.08% | 0.08% |
Dividend yield Trailing 12-month yield. | 1.84% | 1.38% |
AUM Assets under management — bigger funds are typically more liquid. | $45.26B | $49.10B |
YTD return | 18.79% | 23.16% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.61 | 0.41 |
P/E ratio | 21.59 | 30.63 |
Last price | $81.80 | $187.94 |
Inception | — | — |
Issuer | iShares | State Street |
DGRO top holdings
| XOM | ExxonMobil Holdings Corp | 3.33% |
| ABBV | AbbVie Inc | 3.05% |
| MSFT | Microsoft Corp | 3.04% |
| AAPL | Apple Inc | 3.04% |
| JNJ | Johnson & Johnson | 2.78% |
| JPM | JPMorgan Chase & Co | 2.66% |
| PG | Procter & Gamble Co | 2.42% |
| AVGO | Broadcom Inc | 2.40% |
| PM | Philip Morris International Inc | 2.27% |
| HD | The Home Depot Inc | 2.07% |
XLV top holdings
| LLY | Eli Lilly and Co | 16.88% |
| JNJ | Johnson & Johnson | 9.80% |
| ABBV | AbbVie Inc | 7.76% |
| MRK | Merck & Co Inc | 5.49% |
| UNH | UnitedHealth Group Inc | 5.44% |
| TMO | Thermo Fisher Scientific Inc | 3.84% |
| AMGN | Amgen Inc | 3.75% |
| GILD | Gilead Sciences Inc | 3.15% |
| ABT | Abbott Laboratories | 2.74% |
| PFE | Pfizer Inc | 2.59% |
About DGRO
DGRO (iShares Core Dividend Growth ETF) is US stocks with sustained dividend growth. Managed by iShares, the fund carries $45.3B in assets under management, an expense ratio of 0.08%, a dividend yield of 1.84%. Its largest holding is ExxonMobil Holdings Corp (XOM), which represents 3.3% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 6.1%.
About XLV
XLV (Health Care Select Sector SPDR Fund) is S&P 500 health care sector. Managed by State Street, the fund carries $49.1B in assets under management, an expense ratio of 0.08%, a dividend yield of 1.38%. Its largest holding is Eli Lilly and Co (LLY), which represents 16.9% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.